# Vessi Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vessi-medical

- Industry: Medical Devices & Equipment
- Headquarters: Israel
- Website: www.vessimed.com
- Total disclosed funding: $17M
- Latest round: Series A (Feb 14, 2024)
- Investors on record: 3

## About

Based in Misgav, Israel, and founded in 2021 by CEO Eyal Kochavi, Vessi Medical Ltd operates as a developer of a medical device that is used to treat non-muscle-invasive bladder cancer (NMIBC). In February 2024, Vessi Medical Ltd. raised USD 16.5 million in Series A funding co-led by ALIVE, Agriline Ltd, and Trendlines Group. 

Vessi Medical Ltd developed a cryo spray system designed for hollow and humid organs, particularly the bladder. The company’s device utilizes surface cryotherapy to freeze and destroy abnormal tissue, ablating unwanted tissue while minimizing the risk of complications and preserving bladder integrity. In addition, the firm’s Vessi system comprises a standalone console and a disposable catheter for transurethral insertion into the bladder, allowing for visualization and treatment without the need for anaesthesia in some cases. 

The company plans to use the funding from February 2024 to support expansion of its capabilities, clinical studies in Israel and the U.S., and regulatory clearance.

## Funding rounds

- Series A, Feb 14, 2024, $17M — Trendlines Group, Agriline Ltd, ALIVE

## Investors

- Trendlines Group (https://capitalatlas.ai/funds/trendlines-group) — Series A
- Agriline Ltd — Series A
- ALIVE — Series A